As closing arguments begin in landmark opioid trial, City Attorney’s lawsuit has yielded over $120 million of benefits for San Francisco to address the opioid crisis
The federal trial will examine the role of opioid manufacturers Allergan and Teva, distributor Anda, and Walgreens pharmacy in fueling the opioid epidemic in San Francisco